Stocktoria
Edesa Biotech, Inc. EDSA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2008-08-25
Edesa Biotech, Inc. statistics & valuation
Market cap$72.8M
P / B5.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -53.1% | -161.8% | -94.2% | -151.6% | -91.5% |
| Return on equity | -57.7% | -311.4% | -118.8% | -186.9% | -102.2% |
| Current ratio | 10.67 | 0.91 | 3.53 | 4.25 | 8.29 |
| Revenue growth | — | — | — | — | -100.0% |
Source: SEC EDGAR filings · CIK 0001540159 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.